The information on this page is not intended as medical advice or clinician guidance. Please help us be more inclusive of fact-based resources that would add to the quality of this page by sending to: editor@globalbiodefense.com

FDA Authorizes Moderna COVID-19 mRNA Vaccine for Emergency Use

FDA Authorizes Moderna COVID-19 mRNA Vaccine for Emergency Use

On Friday, the Food and Drug Administration announced that it had issued an Emergency Use Authorization (EUA) for Moderna’s mRNA-1273 COVID-19 vaccine, the second COVID-19…

Hospitals Scramble to Prioritize Which Workers Are First for COVID Shots

Hospitals Scramble to Prioritize Which Workers Are First for COVID Shots

If there’s such a thing as a date with destiny, it’s marked on Dr. Taison Bell’s calendar. At noon Tuesday, Bell, a critical care physician,…

Research Reveals How Airflow Inside a Car May Affect COVID-19 Transmission Risk

Research Reveals How Airflow Inside a Car May Affect COVID-19 Transmission Risk

A new study of airflow patterns inside a car’s passenger cabin offers some suggestions for potentially reducing the risk of COVID-19 transmission while sharing rides…

Researchers Adapt Cell Phone Camera for SARS-CoV-2 Detection

Researchers Adapt Cell Phone Camera for SARS-CoV-2 Detection

Researchers have developed an assay that can detect the presence of SARS-CoV-2 in a nasal swab using a device attached to an ordinary smartphone, they…

How COVID-19 Vaccines Will Get From the Factory to Your Community

How COVID-19 Vaccines Will Get From the Factory to Your Community

The two major U.S. developers of the early COVID-19 vaccines are Pfizer/BioNTech and Moderna. They both developed mRNA vaccines, a relatively new type of vaccine.…

Vaccines Against SARS-CoV-2 Will Have Side Effects – That’s A Good Thing

Vaccines Against SARS-CoV-2 Will Have Side Effects – That’s A Good Thing

Takeaways Temporary side effects from vaccines are a normal sign of a developing immune response.Vaccines work by training your immune system to recognize and remember…

View All Featured News



HEADLINE NEWS

Biodefense Headlines – 8 November 2020

Biodefense Headlines – 8 November 2020

News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include COVID-19 surveillance data systems; pandemic impact on measles, polio…

Biodefense Headlines – 2 November 2020

Biodefense Headlines – 2 November 2020

News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include partnering with schools for pandemic flu preparedness; validation analysis…

Interview with a Virus-Hunter

Interview with a Virus-Hunter

Dr. Staples is a CDC epidemiologist who led the response to the tick-borne Heartland virus and created a tracking registry that has documented 50 infections…

View All Headline News


RESEARCH HIGHLIGHTS

Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020

CDC Morbidity and Mortality Weekly Report (MMWR) On January 17, CDC and the U.S. Department of Homeland Security’s Customs and Border Protection began health screenings at U.S.…

Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans

A new University of California, Berkeley, study finds that bats’ fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to…

Steroids Could Do More Harm Than Good in Treating Coronavirus

Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised. A commentary article published in The Lancet concludes that, based on evidence from previous…

A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin

NOTE: The following paper (.pdf) is undergoing accelerated peer-review. Abstract follows: Since the SARS outbreak 18 years ago, a large number of severe acute respiratory syndrome-related coronaviruses…

Coronavirus and Brexit: UK Must Act Quickly Before Being Shut out of Europe’s Health Protection System

The threat posed by 2019-nCoV and the fragmentation of existing health protection systems caused by Brexit call for urgent assessment of cross Europe cooperation, say Mark Flear…

View All Research Journal Highlights

JOURNAL HUBS

“We call on researchers, journals and funders to ensure that research findings and data relevant to this outbreak are shared rapidly and openly to inform the public health response and help save lives.” – Wellcome Trust

NEJM Novel Coronavirus

JAMA Network 2019-nCoV

The Lancet 2019-nCoV Resource Center

Springer Nature Novel Coronavirus Articles

The BMJ Coronavirus Free Online Resources

Elsevier Novel Coronavirus Information Center

BioRxiv Preprint Server *(Caution: information not yet peer-reviewed)

ASM Journal Network Coronavirus Articles American Society for Microbiology

RSTMH Coronavirus Collection


FUNDING | CONTRACTS | GRANTS


Sign up to receive weekly insights from Global Biodefense


INDUSTRY NEWSWIRE

Abbott Launches Laboratory-Based Antibody Blood Test with Manufacturing Scaling Targets

Abbott announced today the launch of its third COVID-19 test, a lab-based serology blood test for the detection of the antibody, IgG, that identifies if a person…

BARDA Facilitates Development of Immunotherapies for COVID-19 Patients

The U.S. Department of Health and Human Services (HHS) will collaborate with multiple non-government organizations on the development of convalescent plasma and hyperimmune globulin immunotherapies. These treatments…

BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19

BARDA and Vela Diagnostics USA, Inc. are entering into a partnership to develop a rapid diagnostic test for use on two instrument platforms to aid in the…

Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19

Ridgeback Biotherapeutics announced clearance by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for an orally available antiviral compound, EIDD-2801, to begin human testing.  This action…

BARDA Supports DiaSorin to Develop a Fully Automated Serology Test to Detect COVID-19 Infections

BARDA is collaborating with DiaSorin to develop a clinical laboratory test to identify people who have been infected with the SARS-COV-2 virus but have recovered. Known as…

View All Industry Newswires


STATE RESOURCES

Arkansas

Arkansas Department of Health

Arkansas Public Health Laboratory

Kentucky

Kentucky Division of Laboratory Service

State Health Officials Actively Monitoring for 2019 Novel Coronavirus 1/29 DPH

District of Columbia
American Samoa